Fiduciary Trust’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,152
| Closed | -$456K | – | 832 |
|
|
2025
Q1 | $456K | Sell |
5,152
-5,000
| -49% | -$488K | 0.01% | 539 |
|
|
2024
Q4 | $885K | Hold |
10,152
| – | – | 0.01% | 380 |
|
|
2024
Q3 | $939K | Hold |
10,152
| – | – | 0.01% | 380 |
|
|
2024
Q2 | $1.09M | Hold |
10,152
| – | – | 0.02% | 327 |
|
|
2024
Q1 | $963K | Hold |
10,152
| – | – | 0.01% | 351 |
|
|
2023
Q4 | $936K | Hold |
10,152
| – | – | 0.02% | 349 |
|
|
2023
Q3 | $510K | Hold |
10,152
| – | – | 0.01% | 432 |
|
|
2023
Q2 | $642K | Hold |
10,152
| – | – | 0.01% | 398 |
|
|
2023
Q1 | $457K | Hold |
10,152
| – | – | 0.01% | 458 |
|
|
2022
Q4 | $445K | Hold |
10,152
| – | – | 0.01% | 470 |
|
|
2022
Q3 | $669K | Hold |
10,152
| – | – | 0.01% | 394 |
|
|
2022
Q2 | $513K | Hold |
10,152
| – | – | 0.01% | 448 |
|
|
2022
Q1 | $649K | Hold |
10,152
| – | – | 0.01% | 423 |
|
|
2021
Q4 | $1.09M | Hold |
10,152
| – | – | 0.02% | 338 |
|
|
2021
Q3 | $1.04M | Hold |
10,152
| – | – | 0.02% | 329 |
|
|
2021
Q2 | $893K | Hold |
10,152
| – | – | 0.02% | 353 |
|
|
2021
Q1 | $987K | Hold |
10,152
| – | – | 0.02% | 330 |
|
|
2020
Q4 | $1.14M | Sell |
10,152
-1,000
| -9% | -$105K | 0.02% | 303 |
|
|
2020
Q3 | $1.03M | Hold |
11,152
| – | – | 0.02% | 288 |
|
|
2020
Q2 | $870K | Hold |
11,152
| – | – | 0.02% | 294 |
|
|
2020
Q1 | $652K | Hold |
11,152
| – | – | 0.02% | 310 |
|
|
2019
Q4 | $893K | Hold |
11,152
| – | – | 0.02% | 294 |
|
|
2019
Q3 | $819K | Hold |
11,152
| – | – | 0.02% | 296 |
|
|
2019
Q2 | $1.05M | Buy |
11,152
+3,152
| +39% | +$260K | 0.03% | 256 |
|
|
2019
Q1 | $640K | Hold |
8,000
| – | – | 0.02% | 313 |
|
|
2018
Q4 | $431K | Hold |
8,000
| – | – | 0.01% | 342 |
|
|
2018
Q3 | $624K | Hold |
8,000
| – | – | 0.02% | 308 |
|
|
2018
Q2 | $508K | Hold |
8,000
| – | – | 0.02% | 316 |
|
|
2018
Q1 | $734K | Hold |
8,000
| – | – | 0.02% | 278 |
|
|
2017
Q4 | $603K | Sell |
8,000
-2,468
| -24% | -$174K | 0.02% | 303 |
|
|
2017
Q3 | $729K | Sell |
10,468
-2,000
| -16% | -$107K | 0.02% | 286 |
|
|
2017
Q2 | $632K | Buy |
12,468
+2,203
| +21% | +$93.5K | 0.02% | 308 |
|
|
2017
Q1 | $410K | Buy |
10,265
+2,422
| +31% | +$86.7K | 0.01% | 345 |
|
|
2016
Q4 | $220K | Hold |
7,843
| – | – | 0.01% | 418 |
|
|
2016
Q3 | $233K | Buy |
+7,843
| New | +$195K | 0.01% | 414 |
|
Other funds holding BPMC
PCM
UOC
Fiduciary Trust's BPMC Position: Q2 2025 in Review
Fiduciary Trust sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 5,152 shares — an estimated $456K sold.
Fiduciary Trust first reported a position in BPMC in Q3 2016 and held it in 35 quarters. The position peaked at $1.14M in Q4 2020. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.
- Fiduciary Trust reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
- Fiduciary Trust sold 5,152 Blueprint Medicines shares in Q2 2025, an estimated $456K.
- Fiduciary Trust first reported a position in Blueprint Medicines in Q3 2016 and held it in 35 quarters.
- Fiduciary Trust's Blueprint Medicines position peaked at $1.14M in Q4 2020.
- 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.
Based on Fiduciary Trust's 13F filing for Q2 2025, filed 14 Aug 2025.